Comparison of Oncologist and Model Estimates of Risk for Hospitalization During Systemic Therapy for Advanced Cancer

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/op/authors/author-center.

Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).

Deb Schrag

Stock and Other Ownership Interests: Merck (I)

Honoraria: Pfizer

Consulting or Advisory Role: JAMA-Journal of the American Medical Association

Research Funding: AACR (Inst), GRAIL (Inst)

Patents, Royalties, Other Intellectual Property: PRISSMM model is trademarked and curation tools are available to academic medical centers and government under creative commons license

Other Relationship: JAMA-Journal of the American Medical Association

Gabriel A. Brooks

This author is a member of the JCO Oncology Practice Editorial Board. Journal policy recused the author from having any role in the peer review of this manuscript.

Consulting or Advisory Role: CareCentrix, UnitedHealthcare, Ipsen

Research Funding: Roche/Genentech (Inst)

Open Payments Link: https://openpaymentsdata.cms.gov/physician/197685

No other potential conflicts of interest were reported.